Biotech News
Medpace Holdings, Inc. Reports First Quarter 2026 Results
Revenue of $706.6 million in the first quarter of 2026 increased 26.5% from revenue of $558.6 million for the comparable prior-year period, representing a backlog conversion rate of 23.3%. Net new business awards were $618.4 million in the first quarter of 2026, representing an increase of 23.7%
